Emerald Bioscience Announces Ophthalmology Scientific Advisory Board Members
Emerald Bioscience, Inc. (GLOBE NEWSWIRE) 6 hrs ago
Long Beach, CA, April 22, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced members of the company’s Ophthalmology Scientific Advisory Board (OSAB). The purpose of the OSAB is to provide scientific and clinical guidance relating to EMBI’s proprietary cannabinoid-based drug platform to address diseases of the eye.
“Emerald Bioscience is leading the development of cannabinoid-based therapeutics to address diseases of the eye. We are honored to have these world-class thought leaders in ophthalmology affiliated with our research programs,” noted Brian Murphy, MD, CEO and Chief Medical Officer of EMBI. “Based on data from our upcoming trials coupled with guidance from our advisors, we plan to examine broadening our efforts into indications beyond glaucoma, particularly those associated with vision loss due to direct damage to the cells comprising the optic nerve.”
The following globally recognized researchers will be serving on the OSAB:
— Louis Pasquale, MD, FARVO, is Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai in New York City. He is a Phi Beta Kappa graduate of Manhattan College and earned his M.D. degree from SUNY Stony Brook where he was selected for Alpha Omega Alpha, the national honor medical society. Dr. Pasquale is Site Chair of the Department of Ophthalmology at Mt. Sinai Hospital and Vice Chair of Translational Ophthalmology Research for the Mount Sinai Healthcare System. He currently serves as Glaucoma Trustee for the Association of Research in Vision and Ophthalmology (ARVO) and is a member of the National Institute of Health’s National Advisory Eye Council. He is a member of multiple editorial boards, including the Journal of Glaucoma, the American Journal of Ophthalmology, and Ophthalmology Glaucoma. Dr. Pasquale is an NIH Principal Investigator with continuous support since 2006.
# – # – # – # – #
Pasquale, Louis [MC????]
# – # – # – # – # 2019-Apr-22 @ 14:56
I believe that Louis is a member of the Class of 1982.
McEneney, Mike (MC1953)
[JR: Thanks, Mike. Much appreciated.]
Pasquale, Louis [MC1982]
# – # – # – # – # 2019-Apr-22 @ 15:09